Interleukin enhancer-binding factor 3 (ILF3) (Internal Region) antibody
-
- Target See all Interleukin enhancer-binding factor 3 (ILF3) Antibodies
- Interleukin enhancer-binding factor 3 (ILF3)
-
Binding Specificity
- Internal Region
-
Reactivity
- Human
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- Un-conjugated
-
Application
- Immunohistochemistry (IHC), ELISA
- Purpose
- ILF3
- Sequence
- QKPSYGSGYQ SHQGQ
- Specificity
- This antibody is expected to recognize isoforms a (NP_036350.2) and d (NP_060090.2).
- Cross-Reactivity
- Cow, Dog, Human, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Grade
- Verified
- Isotype
- IgG
- Top Product
- Discover our top product ILF3 Primary Antibody
-
-
- Application Notes
-
Immunohistochemistry: In paraffin embedded Human Kidney shows nuclear staining in convoluted tubules. Recommended concentration, 2-4 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:32000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- Interleukin enhancer-binding factor 3 (ILF3)
- Alternative Name
- ILF3 (ILF3 Products)
- Background
- ILF3, interleukin enhancer binding factor 3, 90 kDa, DRBF, MMP4, MPHOSPH4, MPP4, NF-AT-90, NF90, NFAR, TCP80, M-phase phosphoprotein 4, dsRNA binding protein NFAR-2/MPP4, interleukin enhancer binding factor 3, nuclear factor associated with dsRNA, nuclear
- Gene ID
- 3609
- NCBI Accession
- NP_036350, NP_060090
- Pathways
- M Phase
-